Loading...

Margaret Fang, MD

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentMedicine
Address533 Parnassus Avenue
San Francisco CA 94117
Phone415-502-7100
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Northwestern UniversityBA, Molecular/Cell Biology, Honors Program in Medical Education1994
    Northwestern University School of MedicineMD1998
    Beth Israel Deaconess Medical CenterInternship/Residency2001Medicine
    Massachusetts General HospitalGeneral Medicine Fellowship2003
    Harvard School of Public HealthMPH2003
    Collapse Awards and Honors
    Society of Hospital Medicine2010Excellence in Research Award
    NIH, AFAR2006Paul B. Beeson Career Development Award In Aging Research
    Society of General Internal Medicine2005Milton W. Hamolsky Award for best research abstract
    California Society of General Internal Medicine2005Clinician Investigator of the Year
    AGS Foundation for Health In Aging2005Hartford Geriatrics Health Outcomes Research Scholar
    American Heart Association2004Elizabeth Barrett-Connor Young Investigator Award
    Massachusetts American College of Physicians2002Associate of the Year
    Beth Israel Deaconess Medical Center2001Lowell McGee Award for top resident teacher
    American College of Physicians2001Joseph E. Johnson National Leadership and Recognition Award
    Beth Israel Deaconess Medical Center2000James Tullis Award for exceptional intellectual enthusiasm
    Northwestern University Medical School1997Jonathan Phillip Reder Award for excellence in academic and extracurricular activities
    Northwestern University1994A&O Award for Upcoming Student Leader

    Collapse Overview 
    Collapse Overview
    Margaret C. Fang is an Associate Professor of Medicine at the UCSF and joined the UCSF Division of Hospital Medicine in 2003. She is a graduate of the Honors Program in Medical Education at Northwestern University Medical School and trained in internal medicine at the Beth Israel Deaconess Medical Center in Boston. Subsequently, she completed a General Medicine Fellowship at the Massachusetts General Hospital and a Masters of Public Health at the Harvard School of Public Health.

    Margaret is the Medical Director of the UCSF Anticoagulation Clinic and devotes the majority of her time towards evaluating the quality, safety, and outcomes associated with anticoagulation therapy, with a particular focus on how to optimize the use of anticoagulants among older adults. She is a member of the ATRIA Study Group, investigating thromboembolic and hemorrhagic outcomes in a cohort of people with atrial fibrillation as well as the lead investigator of the CVRN Venous Thromboembolism Study, a cohort of patients with venous thromboembolic disease. Other research projects include investigating the use of genomic testing to guide warfarin dosing, the use of antithrombotic therapy among people undergoing orthopedic surgery, and assessing trends in risk factors and outcomes related to acute stroke.


    Collapse Research 
    Collapse Research Activities and Funding
    The Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Extended Treatment of Venous Thromboembolism
    Patient-Centered Outcomes Research Institute (PCORI) NOACS-1510-32651Nov 1, 2016 - Dec 31, 2020
    Role: Principal Investigator
    Improving Hospital Outcomes through Patient Engagement: The i-HOPE Study
    Patient-Centered Outcomes Research Institute (PCORI) Nov 1, 2016 - Oct 31, 2018
    Role: Co-Principal Investigator
    Management of Perioperative Anticoagulant Care and Transitions
    UCOP Center for Health Quality and Innovations Jul 1, 2013 - Jun 30, 2016
    Role: Principal Investigator
    Estimating Hemorrhage Risk in Patients with Atrial Fibrillation
    UCSF Clinical and Translational Sciences Institute Jun 1, 2012 - Jun 30, 2013
    Role: Principal Investigator
    Anticoagulation Treatment and Long-Term Outcomes After Venous Thromboembolism
    NIH/NHLBI R01HL103820Sep 1, 2010 - May 31, 2015
    Role: Principal Investigator
    Contemporary Treatment and Outcomes for Atrial Fibrillation in Clinical Practice
    NIH RC2HL101589Sep 30, 2009 - Jul 31, 2012
    Role: Co-Investigator
    Clarification of Optimal Anticoagulation through Genetics Study
    NIH/NHLBI May 1, 2009 - Apr 30, 2015
    Role: Co-Investigator
    Expanding the National Health Accounts
    NIH P01AG031098Feb 1, 2009 - Jan 31, 2015
    Role: Co-Investigator
    Risks of Warfarin for Elders with Atrial Fibrillation
    NIH/NIA K23AG028978Sep 1, 2006 - Aug 31, 2012
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Parks AL, Fang MC. Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding. Semin Thromb Hemost. 2017 Mar 30. PMID: 28359135.
      View in: PubMed
    2. McGrath ER, Go AS, Chang Y, Borowsky LH, Fang MC, Reynolds K, Singer DE. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke. J Am Geriatr Soc. 2016 Dec 30. PMID: 28039855.
      View in: PubMed
    3. Ashburner JM, Go AS, Chang Y, Fang MC, Fredman L, Applebaum KM, Singer DE. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study. J Am Geriatr Soc. 2016 Nov 12. PMID: 27861698.
      View in: PubMed
    4. Dallalzadeh LO, Go AS, Chang Y, Borowsky LH, Fang MC, Singer DE. Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Am Heart Assoc. 2016; 5(7). PMID: 27451456.
      View in: PubMed
    5. Rajkomar A, McCulloch CE, Fang M, et al. The Low Diagnostic Utility of Rechecking Hemoglobins within 24 Hours in Hospitalized Patients. Am J Med. 2016 Jul 21. PMID: 27452681.
      View in: PubMed
    6. Quinn GR, Singer DE, Chang Y, Go AS, Borowsky LH, Fang MC. How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation? Am J Cardiol. 2016 Sep 1; 118(5):697-9. PMID: 27394408.
      View in: PubMed
    7. Patel H, Fang M, Harrison JD, Auerbach A, Kangelaris KN, et al. Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group. J Hosp Med. 2016 Jun 13. PMID: 27294477.
      View in: PubMed
    8. Quinn GR, Fang MC. How can I predict bleeding in my elderly patient taking anticoagulants? Cleve Clin J Med. 2016 May; 83(5):345-8. PMID: 27168509.
      View in: PubMed
    9. Fang MC, Fan D, Sung SH, Witt DM, Schmelzer JR, Steinhubl SR, Yale SH, Go AS. Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study. Med Care. 2016 Feb 25. PMID: 26918401.
      View in: PubMed
    10. Parks AL, Fang MC. Anticoagulation in Older Adults with Multimorbidity. Clin Geriatr Med. 2016 May; 32(2):331-46. PMID: 27113150.
      View in: PubMed
    11. Samuelson B, Go AS, Sung SH, Fan D, Fang MC. Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study. J Hosp Med. 2016 Jun; 11(6):432-4. PMID: 27253585.
      View in: PubMed
    12. Ashburner JM, Go AS, Chang Y, Fang MC, Fredman L, Applebaum KM, Singer DE. Effect of Diabetes and Glycemic Control onĀ Ischemic Stroke Risk in AF Patients: ATRIA Study. J Am Coll Cardiol. 2016 Jan 26; 67(3):239-47. PMID: 26796386.
      View in: PubMed
    13. Delate T, Hsiao W, Kim B, Witt DM, Meyer MR, Go AS, Fang MC. Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism. Thromb Res. 2016 Jan; 137:97-102. PMID: 26585762.
      View in: PubMed
    14. Meyer MR, Witt DM, Delate T, Johnson SG, Fang M, Go A, Clark NP. Thrombophilia testing patterns amongst patients with acute venous thromboembolism. Thromb Res. 2015 Dec; 136(6):1160-4. PMID: 26477821.
      View in: PubMed
    15. Fang MC, Fan D, Sung SH, Witt DM, Yale SH, Steinhubl SR, Go AS. Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study. JAMA Intern Med. 2015 Jun; 175(6):1060-2. PMID: 25894761.
      View in: PubMed
    16. Fang MC. Implications of the new atrial fibrillation guideline. JAMA Intern Med. 2015 May; 175(5):850-1. PMID: 25730502.
      View in: PubMed
    17. Parekh AM, Fang MC. Care as a continuum: will hospital outcomes be influenced by outpatient care? J Hosp Med. 2015 Feb; 10(2):133-4. PMID: 25545772.
      View in: PubMed
    18. Freeman JV, Reynolds K, Fang M, Udaltsova N, Steimle A, Pomernacki NK, Borowsky LH, Harrison TN, Singer DE, Go AS. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):49-58. PMID: 25414270; PMCID: PMC4334705 [Available on 02/01/16].
    19. Ashburner JM, Go AS, Reynolds K, Chang Y, Fang MC, Fredman L, Applebaum KM, Singer DE. Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts). Am J Cardiol. 2015 Jan 1; 115(1):40-6. PMID: 25456871.
      View in: PubMed
    20. Lewis WR, Piccini JP, Turakhia MP, Curtis AB, Fang M, Suter RE, Page RL, Fonarow GC. Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2014 Sep; 7(5):770-7. PMID: 25185244.
      View in: PubMed
    21. Goldsweig AM, Reid KJ, Gosch K, Tang F, Fang MC, Maddox TM, Chan PS, Cohen DJ, Chen J. Contemporary use of dual antiplatelet therapy for preventing cardiovascular events. Am J Manag Care. 2014 Aug; 20(8):659-65. PMID: 25295680; PMCID: PMC4539274.
    22. Quinn GR, Singer DE, Chang Y, Go AS, Borowsky LH, Udaltsova N, Fang MC. Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin. Am J Cardiol. 2014 Aug 15; 114(4):583-6. PMID: 25001151.
      View in: PubMed
    23. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul; 45(7):2160-236. PMID: 24788967.
      View in: PubMed
    24. Fang MC, Coca Perraillon M, Ghosh K, Cutler DM, Rosen AB. Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008. Am J Med. 2014 Jul; 127(7):608-15. PMID: 24680794; PMCID: PMC4125206.
    25. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. Long-term survival after ischemic stroke in patients with atrial fibrillation. Neurology. 2014 Mar 25; 82(12):1033-7. PMID: 24532273; PMCID: PMC3962998.
    26. Shoeb M, Khanna R, Fang M, Sharpe B, Finn K, Ranji S, Monash B. Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies. J Hosp Med. 2014 Apr; 9(4):239-43. PMID: 24493566.
      View in: PubMed
    27. Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH. A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med. 2013 Dec 12; 369(24):2283-93. PMID: 24251361; PMCID: PMC3942158.
    28. Auerbach A, Fang M, Glasheen J, Brotman D, O'Leary KJ, Horwitz LI. BOOST: evidence needing a lift. J Hosp Med. 2013 Aug; 8(8):468-9. PMID: 23873749.
      View in: PubMed
    29. Singer DE, Chang Y, Borowsky LH, Fang MC, Pomernacki NK, Udaltsova N, Reynolds K, Go AS. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013 Jun; 2(3):e000250. PMID: 23782923; PMCID: PMC3698792.
    30. Shoeb M, Fang MC. Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis. 2013 Apr; 35(3):312-9. PMID: 23479259; PMCID: PMC3888359.
    31. Quinn GR, Fang MC. Atrial fibrillation: stroke prevention in older adults. Clin Geriatr Med. 2012 Nov; 28(4):617-34. PMID: 23101573.
      View in: PubMed
    32. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants. Stroke. 2012 Jul; 43(7):1795-9. PMID: 22539546; PMCID: PMC3383879.
    33. You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GY. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e531S-75S. PMID: 22315271; PMCID: PMC3278056.
    34. Fang MC. Selecting the optimal stroke prevention therapy in atrial fibrillation. Ann Intern Med. 2011 Nov 1; 155(9):636-7. PMID: 22041953.
      View in: PubMed
    35. Khanna RR, Karliner LS, Eck M, Vittinghoff E, Koenig CJ, Fang MC. Performance of an online translation tool when applied to patient educational material. J Hosp Med. 2011 Nov; 6(9):519-25. PMID: 22034196.
      View in: PubMed
    36. Rennke S, Fang MC. Hazards of hospitalization: more than just "never events". Arch Intern Med. 2011 Oct 10; 171(18):1653-4. PMID: 21824939.
      View in: PubMed
    37. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011 Jul 19; 58(4):395-401. PMID: 21757117; PMCID: PMC3175766.
    38. Fang MC, Maselli J, Lurie JD, Lindenauer PK, Pekow PS, Auerbach AD. Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery. J Thromb Haemost. 2011 Jul; 9(7):1318-25. PMID: 21535390; PMCID: PMC3129495.
    39. Fang MC. Anticoagulation in people with atrial fibrillation. BMJ. 2011; 342:d530. PMID: 21282259.
      View in: PubMed
    40. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010 Nov; 3(6):624-31. PMID: 20959565; PMCID: PMC3063305.
    41. Singer DE, Fang MC, Go AS. CHA2DS2-VASc risk scheme: not ready for clinical use. Chest. 2010 Oct; 138(4):1020; author reply 1020-1. PMID: 20923808.
      View in: PubMed
    42. Fang MC, Cutler DM, Rosen AB. Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med. 2010 Sep; 5(7):406-9. PMID: 20578049; PMCID: PMC3024589.
    43. Sliwka D, Fang MC. Venous thromboembolism prophylaxis in the United States: still room for improvement. J Gen Intern Med. 2010 Jun; 25(6):484-6. PMID: 20390463; PMCID: PMC2869419.
    44. Kneeland PP, Fang MC. Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence. 2010; 4:51-60. PMID: 20361065; PMCID: PMC2846139.
    45. Mission JF, Kerlan RK, Tan JH, Fang MC. Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients. J Gen Intern Med. 2010 Apr; 25(4):321-5. PMID: 20087675; PMCID: PMC2842553.
    46. Singer DE, Fang MC, Go AS. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation. Arch Intern Med. 2009 Nov 23; 169(21):2032; author reply 2033. PMID: 19933969.
      View in: PubMed
    47. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009 Sep 1; 151(5):297-305. PMID: 19721017; PMCID: PMC2777526.
    48. Kneeland PP, Fang MC. Trends in catheter ablation for atrial fibrillation in the United States. J Hosp Med. 2009 Sep; 4(7):E1-5. PMID: 19753578; PMCID: PMC2919218.
    49. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study. Circ Cardiovasc Qual Outcomes. 2009 Jul; 2(4):297-304. PMID: 20031854; PMCID: PMC2801892.
    50. Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, Singer DE. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009 Mar 17; 119(10):1363-9. PMID: 19255343; PMCID: PMC2733238.
    51. Fang MC, Panguluri P, Machtinger EL, Schillinger D. Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication. Patient Educ Couns. 2009 Jun; 75(3):403-10. PMID: 19171448; PMCID: PMC2740646.
    52. Fang MC. Antithrombotic therapy for the treatment of atrial fibrillation in the elderly. J Interv Card Electrophysiol. 2009 Jun; 25(1):19-23. PMID: 19148730.
      View in: PubMed
    53. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):546S-592S. PMID: 18574273.
      View in: PubMed
    54. Fang MC, Go AS, Chang Y, Borowsky L, Pomernacki NK, Singer DE. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2008 Feb 26; 51(8):810-5. PMID: 18294564; PMCID: PMC3534960.
    55. Fang MC, Chen J, Rich MW. Atrial fibrillation in the elderly. Am J Med. 2007 Jun; 120(6):481-7. PMID: 17524745.
      View in: PubMed
    56. Fang MC, Go AS, Chang Y, Hylek EM, Henault LE, Jensvold NG, Singer DE. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med. 2007 Aug; 120(8):700-5. PMID: 17679129; PMCID: PMC3534961.
    57. Arora V, Fang MC, Kripalani S, Amin AN. Preparing for "diastole": advanced training opportunities for academic hospitalists. J Hosp Med. 2006 Nov; 1(6):368-77. PMID: 17219531.
      View in: PubMed
    58. Fang MC, Go AS, Hylek EM, Chang Y, Henault LE, Jensvold NG, Singer DE. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc. 2006 Aug; 54(8):1231-6. PMID: 16913990; PMCID: PMC3534958.
    59. Fang MC, Machtinger EL, Wang F, Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med. 2006 Aug; 21(8):841-6. PMID: 16881944; PMCID: PMC1831580.
    60. Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005 Sep 20; 112(12):1687-91. PMID: 16157766; PMCID: PMC3522521.
    61. Go AS, Fang MC, Singer DE. Antithrombotic therapy for stroke prevention in atrial fibrillation. Prog Cardiovasc Dis. 2005 Sep-Oct; 48(2):108-24. PMID: 16253651.
      View in: PubMed
    62. Fang MC, Minichiello T, Auerbach AD. Cost considerations surrounding current and future anticoagulant therapies. Cleve Clin J Med. 2005 Apr; 72 Suppl 1:S43-9. PMID: 15853179.
      View in: PubMed
    63. Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004 Nov 16; 141(10):745-52. PMID: 15545674.
      View in: PubMed
    64. Fang MC, McCarthy EP, Singer DE. Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine. Am J Med. 2004 Oct 15; 117(8):575-81. PMID: 15465506.
      View in: PubMed
    65. Fang MC, Singer DE. Anticoagulation for atrial fibrillation. Cardiol Clin. 2004 Feb; 22(1):47-62. PMID: 14994847.
      View in: PubMed
    66. Fang MC, Stafford RS, Ruskin JN, Singer DE. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med. 2004 Jan 12; 164(1):55-60. PMID: 14718322.
      View in: PubMed
    Margaret's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP